Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individuals.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 28 11 2018
medline: 20 8 2020
entrez: 28 11 2018
Statut: ppublish

Résumé

Exposure to airborne particulate matter has been consistently associated with early death and increased morbidity, particularly raising the risk of cardiovascular disease. Obesity, one of the leading cardiovascular disease risk factors, increases susceptibility to the adverse effects of particulate matter exposure. Proprotein convertase subtilisin/kexin type 9 has been related to a large number of cardiovascular risk factors, e.g. atherogenic lipoproteins, arterial stiffness and platelet activation. Thus, the present study was aimed at evaluating, in a series of obese individuals, the effects of particulate matter less than 10 µm in diameter (PM In 500 obese subjects, participating in the cross-sectional Susceptibility to Particle Health Effects, miRNAs and Exosomes (SPHERE) study, we evaluated the effects of long- and short-term PM In obese individuals, more sensitive to the damaging effects of environmental air pollution, PM

Identifiants

pubmed: 30477320
doi: 10.1177/2047487318815320
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0
PCSK9 protein, human EC 3.4.21.-
Proprotein Convertase 9 EC 3.4.21.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

578-588

Commentaires et corrections

Type : CommentIn

Auteurs

Chiara Macchi (C)

1 Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Italy.

Nicola Ferri (N)

2 Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Italy.

Chiara Favero (C)

3 EPIGET Department of Clinical Sciences and Community Health, University of Milan, Italy.

Laura Cantone (L)

3 EPIGET Department of Clinical Sciences and Community Health, University of Milan, Italy.

Luisella Vigna (L)

4 Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Italy.

Angela C Pesatori (AC)

3 EPIGET Department of Clinical Sciences and Community Health, University of Milan, Italy.
4 Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Italy.

Maria G Lupo (MG)

2 Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Italy.

Cesare R Sirtori (CR)

5 Centro Dislipidemie, ASST Grande Ospedale Metropolitano Niguarda, Italy.

Alberto Corsini (A)

1 Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Italy.
6 IRCCS, Multimedica, Italy.

Valentina Bollati (V)

3 EPIGET Department of Clinical Sciences and Community Health, University of Milan, Italy.
4 Fondazione Cà Granda, IRCCS Ospedale Maggiore Policlinico, Italy.

Massimiliano Ruscica (M)

1 Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH